SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
Singh AK, Misra A, Das AK, Behl A, Srivastava A, Paneerselvam A, Chidambaram B, Saboo B, Sethi B, Makkar BM, Bantwal G, Thacker H, Panda J, Kesavadev J, Seshadri KG, Tiwaskar M, Shunmugavelu M, Sahay R, Das S, Agarwal S, Shaikh S, Sharma SK, Gupta S, Bhattacharyya S, Mohan V, Gunupati VK.
Singh AK, et al.
J Assoc Physicians India. 2023 Dec;71(12):62-74. doi: 10.59556/japi.71.0422.
J Assoc Physicians India. 2023.
PMID: 38736056